Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00990392

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

Pilot Study: Topical Antibiotics for Prevention of ICU Central Line Infections

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Fraser Health · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.

Detailed description

Previous studies in the dialysis population have found a reduction in local and system central venous catheter related infections with the application of topical antibiotics to the insertion point. One such study found a mortality benefit with Polysporin Triple Therapy ointment. We intend to determine if this preparation can reduce overall line infection rates in the ICU environment through its application at the time of line insertion and twice more the following week.

Conditions

Interventions

TypeNameDescription
DRUGPolysporin Triple Therapy ointmentPolysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week.
OTHERPetroleum JellyPetroleum jelly applied to the insertion point at the time of CVC placement and twice within the first week.

Timeline

Start date
2009-11-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2009-10-06
Last updated
2015-05-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00990392. Inclusion in this directory is not an endorsement.